1. Medtech Insight
  2. >>Business

Digital Platform Caresyntax Extends Series C To Total $130M Raised

 
• By Marion Webb

Caresyntax raised $130m in total funding to expand commercialization of its software that seeks to reduce variability and improve outcomes in the operating room.

Surgicaldata

Caresyntax Corp., a developer of a digital platform intended to reduce surgery-related complications, added $30 million to its earlier series C round, bringing the total funding raised to $130m. Among the new investors are funds and accounts managed by BlackRock and health insurer ProAssurance, venture capital firm Harmonix and existing backers such as Releyns Group, Europe’s largest medical malpractice insurer, and IPF Partners, Caresyntax said in a 16 September announcement.

The added investment builds on the first stage, announced in April, that was led by PFM Health Sciences, LP and included investments from UnitedHealth Group’s venture fund Optum Ventures, Intel Capital and Lauxera Capital

More from Financing

More from Business

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.

Danaher Faces $350M Tariff Hit, But Says It’s Ready To Absorb The Blow

 
• By Shubham Singh

Despite Danaher’s confident outlook, the company acknowledged near-term profitability fluctuations, particularly in the second quarter. Matt McGrew, Danaher’s CFO, clarified during the company’s first-quarter earnings call on 22 April, that expected operating margin softness in the second quarter – forecast at 25.5% – was not related to tariffs, but to seasonal dynamics in its respiratory diagnostics business.